
Allakos Inc. (NASDAQ: ALLK), relating to the proposed merger with Concentra Biosciences, LLC. Under the terms of the agreement, Concentra Biosciences will acquire Allakos for $0.33 in cash per share of Allakos common stock.
Allakos Inc. (NASDAQ: ALLK), relating to the proposed merger with Concentra Biosciences, LLC. Under the terms of the agreement, Concentra Biosciences will acquire Allakos for $0.33 in cash per share of Allakos common stock.